Suppr超能文献

过氧化物酶体功能障碍与脂肪性肝病

Peroxisome Dysfunction and Steatotic Liver Disease.

作者信息

Vinoy Navia, Huang Gary, Wallace Daniel F, Subramaniam V Nathan

机构信息

Hepatogenomics Research Group, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia.

Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia.

出版信息

Int J Mol Sci. 2025 Aug 27;26(17):8303. doi: 10.3390/ijms26178303.

Abstract

Peroxisomes are cellular organelles involved in multiple metabolic processes, including lipid oxidation, lipid synthesis, and the metabolism of reactive oxygen species. Peroxisomal disorders arise from defects in peroxisomal biogenesis or peroxisomal enzymes. Patients with severe peroxisomal disorders often present with a range of distinctive physical features and congenital malformations, such as neuronal migration defects, renal cysts, and bony stippling in the patellae and long bones. Liver disease has also been reported in some patients with peroxisomal biogenesis disorders, although the exact molecular mechanisms underlying its development remain unclear. Metabolic dysfunction-associated steatotic liver disease (MASLD) is now recognised as one of the most prevalent causes of chronic liver disease globally, due to its widespread incidence and potential for serious complications. This review aims to highlight the possible involvement of peroxisomal defects in the pathogenesis of MASLD.

摘要

过氧化物酶体是参与多种代谢过程的细胞器,包括脂质氧化、脂质合成和活性氧的代谢。过氧化物酶体疾病源于过氧化物酶体生物发生或过氧化物酶体酶的缺陷。患有严重过氧化物酶体疾病的患者通常表现出一系列独特的身体特征和先天性畸形,如神经元迁移缺陷、肾囊肿以及髌骨和长骨的骨质点状沉着。在一些过氧化物酶体生物发生障碍的患者中也报告了肝脏疾病,但其发展的具体分子机制仍不清楚。代谢功能障碍相关脂肪性肝病(MASLD)由于其广泛的发病率和严重并发症的可能性,现已被认为是全球慢性肝病最常见的原因之一。本综述旨在强调过氧化物酶体缺陷可能参与MASLD的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1f4/12427983/a71f5615dd2b/ijms-26-08303-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验